Algo version: 0.98b
Bioptik Technology is listed at the TWO Exchange
Bioptik Technology [4161.TWO]
TWO Sector: Healthcare Industry:Healthcare

Is Bioptik Technology stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Bioptik Technology pays dividends. Last time was Monday 12th of August 2024 where the investors holding the stock on Tuesday 16th of July 2024 were paid TWD0.7 per share. Over the last 8 times between 2015 and 2024, Bioptik Technology has paid TWD4.0889 with an average of TWD0.51 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Bioptik Technology 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was TWD34.33, you would have made a loss of TWD-1.580 per share or -4.60%

Yes, the average daily trading liquidity for Bioptik Technology is TWD163 116 thousand. You should therefore be able to get in and out of your positions relatively fast.

Bioptik Technology has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.27, the company's ability to pay off the debt is normal. Bioptik Technology has a good net profit margin of 11.24% and should have high tolerances against inflation.

We have calculated the inflation risk for Bioptik Technology to be low [0.4 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.